Fig. 2From: Metabolic and cardiorespiratory effects of decreasing lung hyperinflation with budesonide/formoterol in COPD: a randomized, double-crossover, placebo-controlled, multicenter trialOxygen uptake pre-dose and post-dose for patients after administration of (a) BUD/FORM and (b) placebo.*,†. BUD/FORM, budesonide/formoterol; CI, confidence interval; LS, least squares; VO2, oxygen uptake. *Each line represents an individual patient and treatment. †In each panel, the pair of data points with error bars are LS mean (95% CI) values at pre-dose and post-doseBack to article page